Table 2 Treatment modalities for uveal melanoma between March and June in 2018, 2019 and 2020 and between July and October in 2020 from all of the four Ocular Oncology centres in United Kingdom.

From: Impact of COVID-19 pandemic on eye cancer care in United Kingdom

 

Mar–Jun 2018

Mar–Jun 2019

Mar–Jun 2020

Jul–Oct 2020

Ruthenium plaque brachytherapy

95 (39.6%)

96 (34.2%)

50 (36.5%)

60 (31.6%)

Proton beam radiotherapy

68 (28.3%)

84 (29.9%)

24 (17.5%)

45 (23.7%)

Enucleation

53 (22.1%)

66 (23.5%)

38 (27.7%)

44 (23.2%)

Stereotactic radiosurgerya

12

12

9

8

Photodynamic therapy

7

4

5

15

Observationb

3

11

7

7

Others

2

8

4

11

Total

240

281

137

190

  1. aOnly available at Sheffield Ocular Oncology service.
  2. bData not available from London Ocular Oncology service.
  3. Others include local resection, infrared diode and unknown data.